Prosecution Insights
Last updated: October 04, 2026

Illumina Cambridge Limited

Technology area: Biotechnology & Pharmaceuticals

16 pending office actions • 9 art units • 13 examiners • 0 of 16 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days

Analysis

Illumina Cambridge Limited maintains a portfolio with 16 pending office actions, primarily focused within the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 13 distinct examiners and 9 distinct art units, indicating a broad reach across various examination groups. The diversity of 9 distinct art units suggests that the company's innovations intersect with multiple specialized patent classifications.

CROW, ROBERT THOMAS serves as the busiest examiner for the portfolio, currently handling 2 pending office actions. While CROW, ROBERT THOMAS has the highest individual count, the 2 pending actions represent a portion of the 16 total actions pending for the company. This distribution shows that no single examiner dominates the prosecution landscape for Illumina Cambridge Limited. The presence of 13 distinct examiners reflects a strategy where most examiners are managing only a few cases simultaneously.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

16
Total Pending OAs
7
Non-Final OAs
5
Final Rejections
4
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

12
Hard (75%)
3
Medium (19%)
1
Easy (6%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (6%)
§103 only1 (6%)
Double-patenting only1 (6%)
Double-patenting + other2 (12%)
Multi-statute (no §101)11 (69%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

14
Life Sciences
88% of docket
0
Information Tech
0% of docket
1
Communications
6% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
6% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

160 h
Manual time on pending OAs
32 h
Time saved (low, 20%)
56 h
Time saved (mid, 35%)
1.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CROW, ROBERT THOMAS 2 41.7% +32.7%
BERTAGNA, ANGELA MARIE 2 44.7% +46.3%
PARISI, JESSICA DANIELLE 2 75.8% +32.3%
TSAI, TSUNG YIN 1 81.4% +11.7%
BROWN, MINDY G 1 55.9% +44.4%
HORLICK, KENNETH R 1 78.9% +15.3%
TURK, NEIL N 1 51.0% +44.3%
VANN-OJUEKAIYE, KENDRA RAYCHELL 1 0.0% +0.0%
HIBSHMAN, SARAH GRACE 1 38.9% +40.0%
LU, FRANK WEI MIN 1 62.7% +67.7%

Hard Cases (12)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18139689 METHODS AND COMPOSITIONS FOR CLUSTER GENERATION BY BRIDGE AMPLIFICATION PARISI, JESSICA DANIELLE 18d overdue
17564592 METHOD AND SYSTEM EMPLOYING DISTINGUISHABLE POLYMERASES FOR DETECTING TERNARY COMPLEXES AND IDENTIFYING COGNATE NUCLEOTIDES LU, FRANK WEI MIN 4d overdue
17478016 REVERSIBLE MODIFICATION OF NUCLEOTIDES LEE, HOI YAN NMN 9d
17946742 SYSTEMS AND METHODS OF DETECTING DENSELY-PACKED ANALYTES TURK, NEIL N 20d
18613562 DENSLEY-PACKED ANALYTE LAYERS AND DETECTION METHODS TSAI, TSUNG YIN 34d
18419082 COMPOSITIONS AND METHODS FOR AMPLIFYING POLYNUCLEOTIDES BROWN, MINDY G —
18303905 Sequencing Templates Comprising Multiple Inserts and Compositions and Methods for Improving Sequencing Throughput HORLICK, KENNETH R —
18169970 Sequence-Specific Targeted Transposition and Selection and Sorting of Nucleic Acids PARISI, JESSICA DANIELLE —

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18139689 METHODS AND COMPOSITIONS FOR CLUSTER GENERATION BY BRIDGE AMPLIFICATION PARISI, JESSICA DANIELLE 18d overdue
17564592 METHOD AND SYSTEM EMPLOYING DISTINGUISHABLE POLYMERASES FOR DETECTING TERNARY COMPLEXES AND IDENTIFYING COGNATE NUCLEOTIDES LU, FRANK WEI MIN 4d overdue
17946742 SYSTEMS AND METHODS OF DETECTING DENSELY-PACKED ANALYTES TURK, NEIL N 20d
18613562 DENSLEY-PACKED ANALYTE LAYERS AND DETECTION METHODS TSAI, TSUNG YIN 34d
18587683 COMPOSITIONS AND METHODS FOR DENSLEY-PACKED ANALYTE ANALYSIS CROW, ROBERT THOMAS —
18419082 COMPOSITIONS AND METHODS FOR AMPLIFYING POLYNUCLEOTIDES BROWN, MINDY G —
18227657 NUCLEIC ACID SEQUENCING METHOD AND SYSTEM EMPLOYING ENHANCED DETECTION OF NUCLEOTIDE-SPECIFIC TERNARY COMPLEX FORMATION BERTAGNA, ANGELA MARIE —
18303905 Sequencing Templates Comprising Multiple Inserts and Compositions and Methods for Improving Sequencing Throughput HORLICK, KENNETH R —

Top Art Units

Art UnitApps
1681 3
1683 3
1684 2
1693 2
2656 1
1685 1
1798 1
1682 1
1635 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18613562 DENSLEY-PACKED ANALYTE LAYERS AND DETECTION METHODS TSAI, TSUNG YIN 2656 §102§103 Final Rejection 34d Pending Mar 22, 2024
18587683 COMPOSITIONS AND METHODS FOR DENSLEY-PACKED ANALYTE ANALYSIS CROW, ROBERT THOMAS — §103§112DP Non-Final OA — Pending Feb 26, 2024
18419082 COMPOSITIONS AND METHODS FOR AMPLIFYING POLYNUCLEOTIDES BROWN, MINDY G 1685 §103§112Other Non-Final OA — Pending Jan 22, 2024
18227657 NUCLEIC ACID SEQUENCING METHOD AND SYSTEM EMPLOYING ENHANCED DETECTION OF NUCLEOTIDE-SPECIFIC TERNARY COMPLEX FORMATION BERTAGNA, ANGELA MARIE 1681 §102§103§112DP Non-Final OA — Pending Jul 28, 2023
18139689 METHODS AND COMPOSITIONS FOR CLUSTER GENERATION BY BRIDGE AMPLIFICATION PARISI, JESSICA DANIELLE 1684 §102§103 Non-Final OA 18d overdue Pending Apr 26, 2023
18303905 Sequencing Templates Comprising Multiple Inserts and Compositions and Methods for Improving Sequencing Throughput HORLICK, KENNETH R 1681 §103§112 Non-Final OA — Pending Apr 20, 2023
18169970 Sequence-Specific Targeted Transposition and Selection and Sorting of Nucleic Acids PARISI, JESSICA DANIELLE 1684 §103§112 Final Rejection — Pending Feb 16, 2023
18146320 FLOW CELLS AND METHODS BERTAGNA, ANGELA MARIE 1681 §103§112 Final Rejection — Pending Dec 23, 2022
17946742 SYSTEMS AND METHODS OF DETECTING DENSELY-PACKED ANALYTES TURK, NEIL N 1798 §101§112 Final Rejection 20d Pending Sep 16, 2022
17859770 PAIRED-END SEQUENCING METHODS AND COMPOSITIONS VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §102§103§112 Non-Final OA — Pending Jul 07, 2022
17694404 DETECTING METHYLCYTOSINE AND ITS DERIVATIVES USING S-ADENOSYL-L-METHIONINE ANALOGS (xSAMS) HIBSHMAN, SARAH GRACE 1693 §102§103§112 Non-Final OA — Pending Mar 14, 2022
17564592 METHOD AND SYSTEM EMPLOYING DISTINGUISHABLE POLYMERASES FOR DETECTING TERNARY COMPLEXES AND IDENTIFYING COGNATE NUCLEOTIDES LU, FRANK WEI MIN 1683 §103§112 Non-Final OA 4d overdue Pending Dec 29, 2021
17555945 METHODS AND COMPOSITIONS FOR NUCLEIC ACID SEQUENCING HOPPE, EMMA RUTH 1683 §103 Non-Final OA 46d overdue Pending Dec 20, 2021
17525541 ALTERING FLOW CELL SIGNALS GIBBS, TERRA C 1635 DP Non-Final OA — Pending Nov 12, 2021
17478016 REVERSIBLE MODIFICATION OF NUCLEOTIDES LEE, HOI YAN NMN 1693 §103§112Other Final Rejection 9d Pending Sep 17, 2021
17338590 SYSTEMS AND METHODS FOR SEQUENCING NUCLEOTIDES USING TWO OPTICAL CHANNELS CROW, ROBERT THOMAS 1683 §103§112 Non-Final OA — Pending Jun 03, 2021

Managing Illumina Cambridge Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month